Lobbying Relationship


Celgene Corporation

More records

Lobbying firm


More records

  • Issues relating to prescription drugs in health care bills; orphan drug and rare disease bill; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment Act of 2013 (H.R. 460); MODDERN Cures Act (H.R. 3116); H.R. 5657, the FAST Generics Act of 2014; tax extenders package; 21st Century Cures; H.R. 5780, the Protecting the Integrity of Medicare Act.

Duration: to

General Issues: Health Issues, Trade (Domestic & Foreign), Veterans

Spending: about $2,200,000 (But it's complicated. Here's why.)

Agencies lobbied since 2008: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), U.S. Senate,, U.S. Trade Representative (USTR), Treasury - Dept of, Drug Enforcement Administration (DEA), Veterans Affairs - Dept of (VA)

Bills mentioned

H.R.1801: Promoting Financial Literacy and Economic Opportunity Act of 2015

Sponsor: Robin Kelly (D-Ill.)

H.R.460: Human Trafficking Detection Act of 2015

Sponsor: Mark Walker (R-N.C.)

H.R.3116: Quarterly Financial Report Reauthorization Act

Sponsor: Ted Lieu (D-Calif.)

H.R.5657: H-1B and L-1 Visa Reform Act of 2016

Sponsor: Bill Pascrell Jr. (D-N.J.)

H.R.5780: Utah Public Lands Initiative Act

Sponsor: Rob Bishop (R-Utah)

H.R.1801: Cancer Drug Coverage Parity Act of 2013

Sponsor: Brian Higgins (D-N.Y.)

H.R.460: Patients' Access to Treatments Act of 2013

Sponsor: David McKinley (R-W.Va.)

H.R.3116: MODDERN Cures Act of 2013

Sponsor: Leonard Lance (R-N.J.)

H.R.5657: FAST Generics Act of 2014

Sponsor: Steve Stivers (R-Ohio)

H.R.5780: Protecting the Integrity of Medicare Act of 2014

Sponsor: Kevin Brady (R-Texas)

H.R.3230: Veterans Access, Choice, and Accountability Act of 2014

Sponsor: Harold Rogers (R-Ky.)

H.R.4810: Veteran Access to Care Act of 2014

Sponsor: Jeff Miller (R-Fla.)

S.3187: Food and Drug Administration Safety and Innovation Act

Sponsor: Tom Harkin (D-Iowa)

S.1423: Preserving Access to Orphan Drugs Act of 2011

Sponsor: Patrick J. Toomey (R-Pa.)

H.R.2672: Preserving Access to Orphan Drugs Act of 2011

Sponsor: Jim Gerlach (R-Pa.)

S.3697: Creating Hope Act of 2010

Sponsor: Sam Brownback (R-Kan.)

S.1674: Improving Access to Clinical Trials Act of 2009

Sponsor: Ron Wyden (D-Ore.)

H.R.4213: Unemployment Compensation Extension Act of 2010

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.4899: Supplemental Appropriations Act, 2010

Sponsor: David R. Obey (D-Wis.)

H.R.5712: Physician Payment and Therapy Relief Act of 2010

Sponsor: Sander M. Levin (D-Mich.)

Show All Mentioned Bills


Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Robert Dole Senator (KS)
Mark Rayder Dist. Rep., Rep. D. Gallo; L.A.., Rep. R. Frelinghuysen; L.A.., Rep. T. Latham
Earl Pomeroy U.S. Congressman (North Dakota)
Marc Scheineson Associate Commissioner for Leg. Affairs, FDA
Bob Siggins Chief of Staff, Congressman Earl Pomeroy
Marilyn Yager Dep. Ass't to Pres., Office of Public Liaison
Michael Park Health Policy Counsel, Sen. Fin. Cmte
Timothy Trysla Sr. Pol. Adv. Off. of Admin., CMS Off. of Rep. Bill Archer; Soc. Sec. Advisory Coun., Steelman Comm.
Thomas Scully Administrator & Consultant, CMS; Dep. Assistant to President Counselor to the Dir., Dir. for Hum. Res. Vets and Labor Associate Dir. for Legislative Affairs, OMB
Dan Elling Staff Dir., Ways and Means Health Subcmte Prof. Staff, Ways and Means Health Subcmte Health Policy Aide, Rep. Nancy Johnson Legislative Assistant, Rep. Jim Ramstad
Colin Roskey Health Policy Advisor & Counsel, Sen. Fin. Cmte
Eric Shimp Director, ASEAN and Korean Affairs, USTR Director, Korean and South Asian Affairs, USTR U.S. Foreign Service Officer, Department of State
Jennifer Butler n/a
Elinor Hiller n/a
Carolyn Smith n/a
Gina Sherick n/a
Joyce Gresko n/a
Rudy Missmar n/a
Peter Kazon n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page